Microsoft’s $13 billion bet on OpenAI carries huge potential along with plenty of uncertainty
Microsoft’s partnership with OpenAI could mean billions of dollars a year in new revenue, but the investment structure is complicated.
Federal judge suspends FDA abortion pill approval, gives Biden administration time to appeal
A federal judge in Texas on Friday stayed the FDA’s appwroval of the abortion pill mifepristone, but delayed the ruling taking effect for a week, giving time to appeal.
Lawmakers meet with Apple, Disney CEOs as part of talks on competition with China
The trip highlights the key role tech and media industries play in the U.S.’s increasingly complex relationship with China.
Job growth totals 236,000 in March, near expectations as hiring pace slows
The Labor Department reported Friday that payrolls grew by 236,000 for the month, compared to the Dow Jones estimate for 238,000.
Treasury yields tick up ahead of U.S. jobs report, with many markets closed for holiday
U.S. Treasury yields moved higher as investors await the U.S. jobs report and market sentiment on possibly reactions from the Federal Reserve.
Tesla nominates ex-CTO JB Straubel to board of directors
Tesla has nominated former CTO JB Straubel to join its board of directors, according to a proxy filing out Thursday.
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
Alzheimer’s patients who take Leqembi retain the benefits of the treatment even when they stop taking it, new research by Eisai and Biogen shows.
478 tornado reports across 25 states: How a mild winter led to destruction
A picture is emerging of how tornado risks are changing across parts of the country, particularly in areas where social factors compound vulnerabilities to extreme weather.
Pfizer RSV vaccine for older adults should be monitored for nervous system condition Guillain-Barre, scientists say
Scientists said Pfizer’s RSV vaccine for older adults should be monitored for Guillain-Barre, in an article published in the New England Journal of Medicine.
Here are some of RBC’s top stock picks for the second quarter
RBC Capital Markets listed the names that have upside potential in what may be a choppy quarter for stocks.
